FibroBiologics, Inc. Common Stock (FBLG) vs Onconetix, Inc. (ONCO)

A side-by-side comparison of FibroBiologics, Inc. Common Stock and Onconetix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
FibroBiologics, Inc. Common Stock logo
FBLG
FibroBiologics, Inc. Common Stock
$3M
$1.20HealthcareDelayed quote: Oct 6, 2026, 12:04 PM EDT
Onconetix, Inc. logo
ONCO
Onconetix, Inc.
$2M
$0.66HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT

Total return — FBLG vs ONCO

growth of $100 · dividends reinvested · last 3y
FBLG -99.8% (-87.3%/yr)ONCO -100.0% (-97.2%/yr)FBLG compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020252026$0$0
FBLG ONCO

FBLG vs ONCO: by the numbers

  • •FBLG is the larger company ($3M vs $2M market cap).
  • •Both run net losses; FBLG's is the smaller (0.00% vs -1578.79% net margin).

Metrics side by side

Valuation

MetricFBLGONCO
P/S ratioN/A3.69
P/B ratio0.540.18

Profitability

MetricFBLGONCO
Gross margin0.00%80.40%
Operating margin0.00%-778.16%
Net margin0.00%-1578.79%
ROE-391.26%-75.70%
ROIC-286.46%-59.84%

Go deeper

Full FBLG analysisFull ONCO analysisInteractive comparison tool

Dig into the metrics

FibroBiologics, Inc. Common Stock ROEOnconetix ROEFibroBiologics, Inc. Common Stock operating marginOnconetix operating marginFibroBiologics, Inc. Common Stock revenue growthOnconetix revenue growthFibroBiologics, Inc. Common Stock free cash flowOnconetix free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.